Navigation Links
New study in JCSM finds that obesity can predict upper airway obstruction amongst children
Date:4/15/2008

tory events are important to consider amongst overweight children under evaluation for suspected upper airway obstruction.

In any case, obesity can still increase an individual childs risk for developing OSA, a sleep-related breathing disorder that causes your body to stop breathing during sleep. OSA, which can disturb your sleep numerous times on any given night, can result in poor daytime function including excessive sleepiness, as well as an increased risk of stroke, diabetes and heart disease. OSA is a serious sleep disorder that can be harmful, or even fatal, if left untreated.

OSA occurs when the tissue in the back of the throat collapses and blocks the airway. This keeps air from getting into the lungs. OSA occurs in about two percent of young children. It can develop in children at any age, but it is most common in pre-schoolers. OSA often occurs between the ages of three and six years when the tonsils and adenoids are large compared to the throat. OSA appears to occur at the same rate in young boys and girls. OSA also is common in children who are obese, and is more likely to occur in a child who has a family member with OSA.

It is recommended that school-aged children get between 10-11 hours of nightly sleep and children in pre-school between 11-13 hours.

The American Academy of Sleep Medicine (AASM) offers some tips to help your child sleep better:

  • Follow a consistent bedtime routine. Set aside 10 to 30 minutes to get your child ready to go to sleep each night.

  • Establish a relaxing setting at bedtime.

  • Interact with your child at bedtime. Dont let the TV, computer or video games take your place.

  • Keep your children from TV programs, movies, and video games that are not right for their age.

  • Do not let your child fall asleep while being held, rocked, fed a bottle, or while nursing.

    <
    '/>"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study shows increase of hip and knee replacements in the US
2. Study shows decline in work disability due to rheumatoid arthritis
3. Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients
4. Study sheds light on deadly lung disease
5. NovoCure presents results from breast cancer pilot study
6. Mayo-led study finds smoking related to subset of colorectal cancers
7. National hospice study reveals gaps in service
8. Study Points to New Treatments for Polycystic Kidney Disease
9. MRI better than MDCT in detecting endoleaks, study says
10. Personality study shows risk of first depression episode late in life
11. 3T MRI plays significant role in detecting prostate cancer, study says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...way to fight leukemia might be to knock out a spec..., a new study shows// . The findings suggest tha...ght on its own be an effective therapy. But such... with several existing drugs might also offer an e...
...drink heavily during the college days has an incre..., reports researchers// at the American Heart Asso...s. In a small study, Minnesota researchers found...drank heavily had higher levels of C-reactive prot...
...ave identified a subgroup of hard-to-treat breast ...n, rarely used in the treatment of breast tumors. ... this sensitivity, which may help identify patient.... The findings will be tested in a clinical trial ...
...ell-based therapeutic vaccine for pancreatic cance...rom progressing in a handful of patients three yea...ng evidence that the vaccine can trigger a patient...er and offer new insights into how the vaccine cou...
Other Medicine News:Health News:Knocking Out Survival Protein Could Fight Leukemia 2Health News:Alcohol Abuse During College Days Leads to Heart Disease in Later Life 2Health News:Alcohol Abuse During College Days Leads to Heart Disease in Later Life 3Health News:Researchers Have Identified Subgroup Sensitive to the Drug Cisplatin 2Health News:Vaccine for Pancreatic Cancer Halts Progression of Disease in Some Patients 2
(Date:9/4/2008)...ctivity and favorable safety ...Newswire-FirstCall/ -- Idenix,Pharmaceuticals, Inc...gaged,in the discovery and development of drugs fo...s diseases, today announced that it has completed ...n-nucleoside reverse,transcriptase inhibitor (NNRT...
(Date:9/3/2008)...ll/ -- Simcere,Pharmaceutical Group (NYSE: SCR ),...neric pharmaceuticals and manufacturer of the pate...as Endostar) in China,announced the interim resul...st of the SFDA, Simcere initiated a Phase IV clini...peutic efficacy of Endu, a modified,version of rec...
(Date:9/3/2008)...Panacea Pharmaceuticals,Inc. today announced the ...antibodies against human aspartyl (asparaginyl) be...biomarker and therapeutic target. These antibodies...setts Institute of,Technology (MIT) and Panacea ha...evelopment of human cancer diagnostics and therape...
(Date:9/3/2008)...udy in Subjects with ALS, RICHMOND, Calif., Sept....Inc. (Nasdaq: SGMO ) announced today that it has ...aluate its drug, SB-509, in subjects,with ALS, a p...which there,are limited treatment options and no c...rmulation of a plasmid,encoding a zinc finger DNA-...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5After drought ponds keep up with the Joneses 808 1After drought ponds keep up with the Joneses 808 2After drought ponds keep up with the Joneses 808 3Studies Examine Life After Weight Loss Surgery 3715 1Studies Examine Life After Weight Loss Surgery 3715 2Studies Examine Life After Weight Loss Surgery 3715 3Studies Examine Life After Weight Loss Surgery 3715 4Baxter International Third Quarter 2007 Financial Results Conference Call 3712 1James B Hawkins Appointed to IRIDEX Board of Directors 3709 1James B Hawkins Appointed to IRIDEX Board of Directors 3709 2James B Hawkins Appointed to IRIDEX Board of Directors 3709 3
...rstCall/ -- Vanda,Pharmaceuticals Inc. announced t... Sleep Disorders and Research Center in Detroit, M...se III clinical,trial results for VEC-162, Vanda,s... SLEEP 2007, the 21st annual meeting of the,Associ...anda presentation will take place at the Conventio...
...ation during the,early post-operative period compa...ction in nausea in the female,patient population c... - CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambr...ditional data from post-hoc analysis of the recent...ronide) in over 500 patients,with post-operative p...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7
Elongated Loop, Slightly Curved; in Stainless Steel.
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM
AXIOM Artis TA is part of the AXIOM family, which introduces dynamic and efficient workflow into the clinical angiography, card- angiography, and neuroradiology procedures. On the clinical, technical
AXIOM Artis FA is a universal floor-mounted angiographic C-arm system whose flexible system architecture is ideal for vascular and non-vascular diagnostics and interventions. It provides complete erg
Medicine Products: